Fresenius 1Q Adjusted Net Profit Rose on Higher Revenue
May 06 2020 - 12:44AM
Dow Jones News
By Matteo Castia
Fresenius SE & Co. said Wednesday that first-quarter
adjusted net profit rose on higher sales, and backed its full-year
guidance excluding the positive and negative effects of the
coronavirus pandemic on the business.
Guidance for the whole year which takes into consideration the
pandemic will be given out with the second-quarter results, it
said.
The German provider of health products and services said
adjusted net profit for the quarter was 465 million euros ($505.3
million) compared with EUR457 million a year earlier.
Sales rose 8% year-on-year to EUR9.10 billion, beating the
EUR8.95 billion market consensus.
At Fresenius Medical Care, the group's dialysis division, net
profit rose 4% on the year to EUR283 million, while sales increased
9% to EUR4.49 billion supported by growth in all regions.
Fresenius Medical Care expects both revenue and net income to
rise at a rate in the mid to high single digits this year, the
company said.
Write to Matteo Castia at matteo.castia@dowjones.com
(END) Dow Jones Newswires
May 06, 2020 01:29 ET (05:29 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2024 to May 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From May 2023 to May 2024